Only losing a pound a week on Mounjaro — is that normal?

Why a pound a week may be exactly where you should be right now

The clinical trial data for tirzepatide (including the SURMOUNT-1 study, published in the New England Journal of Medicine) showed average weight reduction of around 20–21% over 72 weeks at the highest dose. That's not a dramatic first-month number; it's an average spread across nearly a year and a half, across thousands of participants who had weeks where very little happened and weeks where progress picked up again. If you're wondering whether only losing 1 pound a week on Mounjaro is normal for this stage of treatment, the short answer is that it often is, and our dedicated page looks at why in detail. A one-pound weekly loss over 52 weeks is 52 pounds. That outcome would put many people well inside the range seen in trials.

There's also the dose question. Mounjaro starts at 2.5 mg, a dose chosen to help your body adjust rather than to drive maximum weight loss from day one. If you're still at 2.5 mg or 5 mg, the appetite effect you're feeling is a fraction of what you may experience as you titrate. Expecting a top-dose result from a starter dose is a common source of early frustration, and it's worth naming plainly. Our overview of how weight loss tends to progress on Mounjaro covers this stage-by-stage picture in more detail.

One final thing worth sitting with: muscle weighs more than fat by volume. If you've started moving more, you may be losing fat and gaining a small amount of lean mass at the same time. The scale may understate your progress.

The factors your prescriber would actually look at before changing anything

When a prescriber reviews slower-than-expected progress, they don't look at one week in isolation. They look at the arc: how long you've been at the current dose, whether the rate has been consistently around a pound or varied, and whether there are lifestyle factors that could be pulling against the medicine. Sleep deprivation, for instance, raises ghrelin (a hunger-signalling hormone) and cortisol, both of which can blunt the appetite-reduction effect tirzepatide is working to produce. Stress has a similar mechanism.

Dietary composition matters alongside caloric intake. Mounjaro slows gastric emptying, which tends to reduce appetite, but if meals are very high in rapidly absorbed carbohydrates, blood-sugar swings can reassert hunger signals faster than expected. Protein adequacy is particularly important: keeping protein relatively high helps preserve muscle during weight loss, which in turn protects your resting metabolic rate. The NHS patient information for tirzepatide covers how to take the medicine alongside lifestyle changes.

Your prescriber will also consider whether a dose review is appropriate. NICE's guidance on tirzepatide (TA1026) notes that continuing treatment should be reviewed if less than 5% weight loss has occurred after six months at the highest tolerated dose. That's a six-month horizon at the ceiling dose, not a four-week window at a lower one. If you want to read more about what losing two pounds a week on Mounjaro looks like by comparison, that page puts the upper end of typical loss into context.

When slower progress is actually a signal worth acting on

There are situations where a sustained plateau or very slow loss does warrant a proper clinical conversation, rather than patience. If you've been at your maintenance dose for three months or more and the trend has been flat rather than just slow, that's worth raising. Similarly, if you're experiencing side effects that are making it hard to eat adequately (not because appetite is reduced, but because nausea is causing you to skip meals or avoid food groups) that can paradoxically slow loss by reducing muscle mass and triggering the body's conservation response.

Side effects from tirzepatide are most commonly gastrointestinal: nausea, loose stools, reflux, or a general feeling of fullness that tips into discomfort. These usually settle with time, particularly after the first week or two at a new dose. But if they're not settling, a prescriber can advise on strategies (timing of injections, meal size, pace of titration) rather than leaving you to manage alone. Some people also notice changes to their hair during treatment, and if that applies to you, our page on losing hair on Mounjaro explains what tends to cause it and what to do. Our team covers exactly this kind of question through seven-day aftercare, not just at the point of prescription. You can also find practical answers about treatment through our full FAQ section.

One practical note: many people find their progress looks different after breaks in routine, a holiday week, or a month where orders didn't go out until after payday. If there's been a gap in treatment, your body may have partially reset its response to the medicine, and the first few weeks back can feel like starting over. That's worth flagging to your prescriber rather than interpreting as the medicine not working.

How to have the right conversation with your prescriber about this

This is genuinely a clinical question, not just a reassurance one. The variables (your dose, how long you've been on it, what you're eating, how you're sleeping, your starting BMI, your body composition) all interact. No general page can tell you whether your pace is right for you specifically; a prescriber who knows your case can. If you're on Mounjaro through another service and have concerns about progress, you can switch: transfer patients at nume, sorry. At our pharmacy provide evidence of their current treatment and dose, and a prescriber reviews the full picture before any repeat or change.

You can read more about what tirzepatide is and how it works in the full tirzepatide guide, or explore how it compares to other treatment options through our weight-loss treatment overview. If you're finding that you're only losing 1lb a week on Mounjaro and want a detailed look at whether that points to anything worth addressing, that page works through the most common reasons and when to act. If your progress has raised questions about whether your treatment plan is right for you, the best next step is a clinical conversation. Speak to our prescribers through a free consultation, the same day you submit, a GPhC-registered prescriber reads your answers.